CAPLIN POINT LABORATORIES LTD.CC

CAPLIN POINT LABORATORIES LTD.

2,311.05INRD
−3.37%
At close at Dec 20, 11:08 UTC
INR
No trades
See on Supercharts

CAPLIPOINT fundamentals

Key facts

Market capitalization‪181.80 B‬INR
Founded
CEO
Website
About

Caplin Point Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It offers antibiotics, non-steroidal anti-inflammatory drugs (NSAIDS), ophthalmic, pain management, and anti-ulcer products. The company was founded on April 16, 1990 and is headquartered in Chennai, India.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪181.80 B‬‬
Price to earning ratio (P/E)
37.00x
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
37.00x
Price to sales ratio (P/S)
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

CAPLIPOINT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company